Radiation Oncology Market Share Will Increase at 4.6% CAGR Globally by 2030 | By AMR

Radiation oncology is a specialized field of medicine that focuses on using high-energy radiation to treat cancer and other medical conditions. By precisely targeting cancer cells and damaging their DNA, radiation therapy plays a crucial role in eradicating tumors and preventing their growth. The global radiation oncology market size was valued at $7.79 billion in 2021, and is projected to reach $15.23 billion by 2030, growing at a CAGR of 7.8% from 2022 to 2030.

Radiation Oncology Market in Short:

CAGR: 7.8%
Current Market Size: USD 15.23 Billion
Fastest Growing Region: APAC
Largest Market: North America
Projection Time: 2022-2030
Base Year: 2022

Download Free Sample Updated PDF: (Including Full TOC, Table & Figures) –
https://www.alliedmarketresearch.com/request-sample/18888

Q1. What are the driving factors and opportunities in the global radiation oncology market?

A. Increasing prevalence and mortality rate of cancer patients, changes in lifestyle & increase in consumption of highly processed foods along with technological advancements in technology like image guided and intensity modulated radiation therapy, digital imaging, and computer controlled linear accelerators are considered to be the drivers of the global radiation oncology market.

A. Breast Cancer sub-segment of the application wise industry acquired the maximum share of the global radiation oncology Market in 2021.

Value Propositions Related to The Report:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

Inquire Your Every Doubt Here:
https://www.alliedmarketresearch.com/purchase-enquiry/18888

This non-invasive treatment option can be used alone or in combination with surgery and chemotherapy, depending on the type and stage of cancer. With advanced technology and expert care, radiation oncology continues to contribute to improved cancer outcomes and enhanced quality of life for patients worldwide.

Among the analyzed regions, North America is expected to account for the highest revenue in the market in the forecasted years, followed by Europe, Asia-Pacific, LAMEA. North America has the most developed and advanced healthcare infrastructure which is influencing the adoption of radiation oncology techniques by cancer patients.

Major Key Market Players in the Industry –

• BD, Isoray Inc.,
• Provision Healthcare,
• Varian Medical Systems, Inc.,
• Elekta AB,
• Accuray Incorporated,
• Mevion Medical Systems,
• IBA Worldwide,
• Nordion (Canada) Inc.,
• Panacea Medical Technologies Pvt. Ltd

Market: By Region Outlook

• North America (U.S., Canada, Mexico)
• Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
• LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)

Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/radiation-oncology-market/purchase-options

Important Questions Being Answered by This Market Report Are –

Q1. What is the total market value of Radiation Oncology Market report?

Q2. What would be forecast period in the market report?

Q3. What is the market value of Radiation Oncology Market in 2032?

Q4. Which is base year calculated in the Radiation Oncology Market report?

Key findings of the study –

• Based on type, external beam radiation therapy sub-segment accounted for highest revenue share in 2019.
• Based on application, breast cancer sub-segment accounted for a significant market size in 2019.
• Based on region, the North America market had a major share of the radiation oncology market in 2019 and is expected to maintain its dominance in the next years.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com